Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 301

1.

Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.

Bhavsar NA, Köttgen A, Coresh J, Astor BC.

Am J Kidney Dis. 2012 Aug;60(2):233-40. doi: 10.1053/j.ajkd.2012.02.336. Epub 2012 Apr 28.

2.

Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).

Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG.

Am J Kidney Dis. 2012 Dec;60(6):904-11. doi: 10.1053/j.ajkd.2012.05.014. Epub 2012 Jun 30.

3.

High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.

Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.

Nephrol Dial Transplant. 2011 Nov;26(11):3581-8. doi: 10.1093/ndt/gfr135. Epub 2011 Apr 5.

PMID:
21467131
4.

Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.

Xue W, Xie Y, Wang Q, Xu W, Mou S, Ni Z.

Nephrology (Carlton). 2014 Apr;19(4):186-94. doi: 10.1111/nep.12173.

PMID:
24165570
5.

Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.

Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, Waikar SS, Mifflin TE, Zhang X, Xie D, Hsu CY, Feldman HI, Coresh J, Vasan RS, Kimmel PL, Liu KD; Chronic Kidney Disease Biomarkers Consortium Investigators.

Diabetologia. 2015 Jan;58(1):188-98. doi: 10.1007/s00125-014-3389-3. Epub 2014 Oct 15.

6.

Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).

Peralta C, Scherzer R, Grunfeld C, Abraham A, Tien P, Devarajan P, Bennett M, Butch A, Anastos K, Cohen M, Nowicki M, Sharma A, Young M, Sarnak M, Parikh C, Shlipak M.

HIV Med. 2014 May;15(5):291-300. doi: 10.1111/hiv.12113. Epub 2013 Dec 3.

7.

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M.

Clin J Am Soc Nephrol. 2009 Feb;4(2):337-44. doi: 10.2215/CJN.03530708. Epub 2009 Jan 28.

8.

Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure.

Verbrugge FH, Dupont M, Shao Z, Shrestha K, Singh D, Finucan M, Mullens W, Tang WH.

J Card Fail. 2013 Sep;19(9):621-8. doi: 10.1016/j.cardfail.2013.07.004.

9.

Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).

van de Vrie M, Deegens JK, van der Vlag J, Hilbrands LB.

Am J Kidney Dis. 2014 Apr;63(4):573-6. doi: 10.1053/j.ajkd.2013.10.010. Epub 2013 Nov 21.

PMID:
24268306
10.

Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).

Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, Holt SG.

Nephrol Dial Transplant. 2013 Jun;28(6):1569-79. doi: 10.1093/ndt/gfs586. Epub 2013 Jan 16.

PMID:
23328709
11.

Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?

Matys U, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S.

Adv Med Sci. 2013;58(2):353-61. doi: 10.2478/v10039-012-0077-8.

PMID:
24384771
12.

Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Foster MC, Coresh J, Bonventre JV, Sabbisetti VS, Waikar SS, Mifflin TE, Nelson RG, Grams M, Feldman HI, Vasan RS, Kimmel PL, Hsu CY, Liu KD; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1956-63. doi: 10.2215/CJN.02590315. Epub 2015 Sep 8.

13.

Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.

Kim SS, Song SH, Kim IJ, Kim WJ, Jeon YK, Kim BH, Kwak IS, Lee EK, Kim YK.

Diabetes Metab Res Rev. 2014 Nov;30(8):736-41. doi: 10.1002/dmrr.2546.

PMID:
24687388
14.

NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.

Holzscheiter L, Beck C, Rutz S, Manuilova E, Domke I, Guder WG, Hofmann W.

Clin Chem Lab Med. 2014 Apr;52(4):537-46. doi: 10.1515/cclm-2013-0693.

PMID:
24243749
15.

Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.

Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML, Deng RT, Zheng L, Wang SB, Pen LF, Wang Q.

Endocrine. 2012 Feb;41(1):82-8. doi: 10.1007/s12020-011-9509-7. Epub 2011 Jul 21.

PMID:
21779943
16.

Urinary markers of kidney injury and kidney function decline in HIV-infected women.

Shlipak MG, Scherzer R, Abraham A, Tien PC, Grunfeld C, Peralta CA, Devarajan P, Bennett M, Butch AW, Anastos K, Cohen MH, Nowicki M, Sharma A, Young MA, Sarnak MJ, Parikh CR.

J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):565-73. doi: 10.1097/QAI.0b013e3182737706.

17.

Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease.

Hasegawa M, Ishii J, Kitagawa F, Takahashi K, Hayashi H, Koide S, Tomita M, Takahashi H, Ozaki Y, Yuzawa Y.

Heart Vessels. 2015 Jan;30(1):81-8. doi: 10.1007/s00380-013-0454-7. Epub 2013 Dec 31.

PMID:
24378882
18.

APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.

Jotwani V, Shlipak MG, Scherzer R, Parekh RS, Kao WH, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Parikh CR, Estrella MM.

Am J Kidney Dis. 2015 Jun;65(6):889-98. doi: 10.1053/j.ajkd.2015.02.329. Epub 2015 Apr 24.

19.

Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.

Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY; Chronic Renal Insufficiency Cohort (CRIC) study investigators.

Kidney Int. 2013 May;83(5):909-14. doi: 10.1038/ki.2012.458. Epub 2013 Jan 23.

20.

No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT.

Kooiman J, van de Peppel WR, Sijpkens YW, Brulez HF, de Vries PM, Nicolaie MA, Putter H, Huisman MV, van der Kooij W, van Kooten C, Rabelink TJ.

Eur Radiol. 2015 Jul;25(7):1926-34. doi: 10.1007/s00330-015-3624-4. Epub 2015 Mar 15.

Supplemental Content

Support Center